OS10.5.A Modeling immunocompetent tumor microenvironment in glioblastoma patient-derived orthotopic xenografts
Abstract Background To date, glioblastoma (GBM) remains a fatal disease, with a median overall survival of roughly over a year. There is a crucial need of new treatment options, yet most clinical trials have failed partly due to the lack of predictive preclinical model systems. Currently, most patie...
Saved in:
Published in | Neuro-oncology (Charlottesville, Va.) Vol. 24; no. Supplement_2; pp. ii21 - ii22 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
US
Oxford University Press
05.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!